Why the study?
Does female gender affect the risk of major cardiac outcomes compared to male gender in adult patients with congenital heart disease?
Cohort (n=7,414)
Yes
Does female gender affect the risk of major cardiac outcomes compared to male gender in adult patients with congenital heart disease?
Answers are grounded in this paper and cite their sources.
In adults with congenital heart disease, gender is significantly associated with the risk of specific major cardiac outcomes, highlighting the need for sex-specific risk stratification.
BACKGROUND: Gender differences in prognosis have frequently been reported in cardiovascular disease but less so in congenital heart disease. We investigated whether gender is associated with outcome in adult patients with congenital heart disease. METHODS AND RESULTS: From the CONgenital CORvitia (CONCOR) national registry for adults with congenital heart disease, 7414 patients were identified. All outcomes before entry into the registry and during subsequent follow-up were recorded, and differences between men and women were analyzed with the underlying congenital heart defect taken into account. Median age at the end of follow-up was 35 years (range, 17 to 91 years); 49.8% were female. No gender difference in mortality was found. Women had a 33% higher risk of pulmonary hypertension (odds ratio [OR]=1.33; 95% CI, 1.07 to 1.65; P=0.01), a 33% lower risk of aortic outcomes (OR=0.67; 95% CI, 0.50 to 0.90; P=0.007), a 47% lower risk of endocarditis (OR=0.53; 95% CI, 0.40 to 0.70; P<0.001), and a 55% lower risk of an implantable cardioverter-defibrillator (OR=0.45; 95% CI, 0.26 to 0.80; P=0.006). Furthermore, the risk of arrhythmias appeared to be lower in women (OR=0.88; 95% CI, 0.77 to 1.02; P=0.08). CONCLUSIONS: The risk of several major cardiac outcomes in adult patients with congenital heart disease appears to vary by gender.
No takes yet. Share an insight, caveat, or question.
Verheugt et al. (2008) conducted a cohort in Adult congenital heart disease (n=7,414). Female gender vs. Male gender was evaluated on Pulmonary hypertension (OR 1.33, 95% CI 1.07 to 1.65, p=0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: